Double-blind, randomized placebo-controlled, dose-response study of a safety and efficacy of Botulinum Toxin Type A in subjects with Crow's Feet.

Diane Roseeuw, Arlette De Coninck, N.j. Lowe, B. Ascher, M. Heckman, C. Kumar, S. Fraczek, N. Eadie

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

127 Citations (Scopus)
Original languageEnglish
Title of host publicationdermatologic surgery 2005; 31: 257-262
Publication statusPublished - 2005

Bibliographical note

dermatologic surgery 2005; 31: 257-262

Cite this